Home » Topics » Conferences

Conferences
RSS

At WCLC, early steps towards success against SCLC

Sep. 10, 2021

GRC-39815 shows efficacy in models of smoke-induced COPD

Sep. 10, 2021

STM-2457: a first-in-class METTL3 inhibitor with preclinical proof of concept in AML models

Sep. 10, 2021

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

Sep. 10, 2021

Discovery of novel antibiotic class of tethered macrocyclic peptides

Sep. 10, 2021

Small-molecule OXS-7417 shows in vivo AML antitumoral effects

Sep. 10, 2021

AFYX Therapeutics presents preclinical data on anti-TNF antibody delivery through adhesive patch

Sep. 10, 2021

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

Sep. 9, 2021

GABA-A alpha5 PAM RO-7015738 presented for neurological disorders

Sep. 9, 2021

New MAP4K4 inhibitors identified for suppressing cardiac muscle cell death

Sep. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...